Neuroimmunology, Inst. of Clinical Chemistry and Laboratory Medicine, Department of Neurology Kiel University, Kiel, Germany

Following his molecular biology master and medical degree at the University of Hamburg, Prof Leypoldt completed a neurologic residency and research fellowships in immune mechanisms of stroke in Hamburg, Germany. Focusing on the emerging field of autoimmune encephalitis, he joined Professor Josep Dalmau’s lab at the IDIBAPS in Barcelona as a research fellow.

During that time, Frank participated in discovering viral triggers of brain autoimmunity and in establishing the first passive infusion animal model of anti-NMDA receptor encephalitis.

In 2014, Frank relocated to Kiel, Germany setting up his own laboratory and research group, a neuroimmunology outpatient clinic and continuing his medical training with a second residency in laboratory medicine.

Since 2015, Professor Leypoldt has a Senior Clinician Scientist faculty position with Laboratory Medicine and Neurology bringing together research, diagnostics and clinics in antibody-associated neurologic diseases.

He is currently Head of the neuroimmunology section at the University-Hospital Schleswig Holstein Kiel. Frank is a speaker and PI in a large collaborative German Research project (GENERATE) and European research initiative as well as part of the European and German guideline committees.

During the past 10 years, he has studied causes, phenotypic spectrum, mechanisms and treatment of autoimmune encephalitis (AE), viral triggers of brain autoimmunity, passive infusion animal models of AE, CSF and serum diagnostics, overlapping syndromes of AE and demyelinating diseases, CSF biomarkers, on brain metabolism and comparative genetic predisposition in AE and treatment response.